NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

CytoDyn Inc (OTCQB: CYDY)

 
CYDY Technical Analysis
1
As on 9th Jun 2023 CYDY STOCK Price closed @ 0.28 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CYDYSTOCK Price

Open 0.30 Change Price %
High 0.31 1 Day N/A N/A
Low 0.27 1 Week 0.00 0.00
Close 0.28 1 Month 0.00 0.00
Volume 1220823 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
OTCQB USA Most Active Stocks
BMIX 0.01 %
MOBQ 0.18 %
FNMA 0.45 %
ALPP 3.56 0.00%
ALPP 3.56 0.00%
SHMP 0.06 %
NWBO 0.73 %
VPLM 0.08 %
NLST 3.72 %
SRNA 2.78 14.88%
 
OTCQB USA Top Gainers Stocks
EWLUD 0.45 275.00%
HCAND 0.02 100.00%
PMMCF 0.34 55.56%
PMMCF 0.34 55.56%
TUMIF 0.09 50.00%
EXDI 0.82 38.98%
NVMDF 0.27 35.00%
NVMDF 0.27 35.00%
GYRRF 0.24 33.33%
QTRRF 0.10 25.00%
 
OTCQB USA Top Losers Stocks
ETST 0.03 -25.00%
ETST 0.03 -25.00%
FDMSF 0.03 -25.00%
EMPR 19.46 -20.73%
EMPR 19.46 -20.73%
IFNY 0.04 -20.00%
UBMRD 0.56 -15.15%
HARY 0.06 -14.29%
HARY 0.06 -14.29%
NPDCF 0.06 -14.29%
 
 
CYDY
Daily Charts
CYDY
Intraday Charts
Whats New @
Bazaartrend
CYDY
Free Analysis
 
CYDY Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
CYDY Forecast September 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
CYDY Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
CYDY Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
CYDY Other Details
Segment EQ
Market Capital 831841920.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CYDY Address
CYDY
 
CYDY Latest News
 
Your Comments and Response on CytoDyn Inc
 
CYDY Business Profile
CytoDyn Inc. operates as a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of human immunodeficiency virus (HIV), cancer, immunology, and novel coronavirus disease (COVID-19). The company has completed a Phase 2b pivotal trial using leronlimab in combination with antiretroviral therapies in HIV-infected treatment-experienced patients, as well as completed a Phase 2b/3 investigative trial with leronlimab as a once-weekly monotherapy for HIV-infected patients. It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Address: 1111 Main Street, Vancouver, WA, United States, 98660
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service